Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients

Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients

States Association of American Physicians and Surgeons (AAPS)

To date, the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, writes AAPS, in observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill.

https://finance.yahoo.com/news/hydroxychloroquine-90-percent-chance-helping-155637974.html


Sequential CQ / HCQ Research Papers and Reports

January to April 20, 2020

Executive Summary Interpretation of the Data In This Report

The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5% in elderly patients. It avoids worsening and clears virus persistence and contagious infectivity in most cases.

https://docs.google.com/document/d/1545C_dJWMIAgqeLEsfo2U8Kq5WprDuARXrJl6N1aDjY/edit#


The probabilities of clinical success using

hydroxychloroquine with or without azithromycin +/- zinc

against the novel betacoronavirus, SARS-CoV-2

(Use the link below to access the table)

https://drive.google.com/file/d/1w6p_HqRXCrW0_wYNK7m_zpQLbBVYcvVU/view

Leave a Reply